发明公开
EP1242049A1 HLA CLASS I A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND VACCINE COMPOSITIONS
审中-公开
HLA-I类A2肿瘤相关抗原肽和疫苗
- 专利标题： HLA CLASS I A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND VACCINE COMPOSITIONS
- 专利标题（中）： HLA-I类A2肿瘤相关抗原肽和疫苗
-
申请号： EP00986510.6申请日： 2000-12-13
-
公开(公告)号： EP1242049A1公开(公告)日： 2002-09-25
- 发明人: FIKES, John , SETTE, Alessandro , SIDNEY, John , SOUTHWOOD, Scott , CELIS, Esteban , KEOGH, Elissa , CHESNUT, Robert
- 申请人： Epimmune Inc.
- 申请人地址： 5820 Nancy Ridge Drive San Diego, CA 92121 US
- 专利权人： Epimmune Inc.
- 当前专利权人： Epimmune Inc.
- 当前专利权人地址： 5820 Nancy Ridge Drive San Diego, CA 92121 US
- 代理机构： Cripps, Joanna Elizabeth
- 优先权： US170448P 19991213; US543608 20000405; US583200 20000530
- 国际公布： WO01041741 20010614
- 主分类号： A61K9/127
- IPC分类号： A61K9/127 ; A61K38/00 ; A61K39/00
摘要：
A composition or vaccine composition comprising at least one peptide that has less than 600 contiguous amino acids having 100 % identity to a native sequence of CEA, HER2/neu, MAGE2, MAGE3, or p53, the peptide further comprising at least one epitope selected from Table 6.
信息查询
